1. Home
  2. CLLS vs JMSB Comparison

CLLS vs JMSB Comparison

Compare CLLS & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • JMSB
  • Stock Information
  • Founded
  • CLLS 1999
  • JMSB 2005
  • Country
  • CLLS France
  • JMSB United States
  • Employees
  • CLLS N/A
  • JMSB N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • JMSB Major Banks
  • Sector
  • CLLS Health Care
  • JMSB Finance
  • Exchange
  • CLLS Nasdaq
  • JMSB Nasdaq
  • Market Cap
  • CLLS 299.0M
  • JMSB 270.0M
  • IPO Year
  • CLLS 2007
  • JMSB N/A
  • Fundamental
  • Price
  • CLLS $2.85
  • JMSB $20.33
  • Analyst Decision
  • CLLS Buy
  • JMSB Buy
  • Analyst Count
  • CLLS 1
  • JMSB 2
  • Target Price
  • CLLS $4.00
  • JMSB $22.50
  • AVG Volume (30 Days)
  • CLLS 199.3K
  • JMSB 13.8K
  • Earning Date
  • CLLS 08-04-2025
  • JMSB 10-22-2025
  • Dividend Yield
  • CLLS N/A
  • JMSB 1.49%
  • EPS Growth
  • CLLS N/A
  • JMSB 688.28
  • EPS
  • CLLS N/A
  • JMSB 1.32
  • Revenue
  • CLLS $63,438,000.00
  • JMSB $56,750,000.00
  • Revenue This Year
  • CLLS N/A
  • JMSB $18.36
  • Revenue Next Year
  • CLLS $4.90
  • JMSB $12.36
  • P/E Ratio
  • CLLS N/A
  • JMSB $15.31
  • Revenue Growth
  • CLLS 223.09
  • JMSB 59.00
  • 52 Week Low
  • CLLS $1.10
  • JMSB $13.81
  • 52 Week High
  • CLLS $3.24
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 59.27
  • JMSB 65.58
  • Support Level
  • CLLS $2.71
  • JMSB $18.75
  • Resistance Level
  • CLLS $3.08
  • JMSB $19.53
  • Average True Range (ATR)
  • CLLS 0.20
  • JMSB 0.37
  • MACD
  • CLLS -0.03
  • JMSB 0.09
  • Stochastic Oscillator
  • CLLS 61.67
  • JMSB 95.45

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: